CALR and neoplasm: Although the anticancer agent-induced release of these DAMPs is associated with the induction of antitumor immunity, research has shown that DAMPs such as HMGB1, CRT, and ATP are also involved in tumor progression [7], metastasis [8], and drug resistance [9], thereby representing a double-edged sword [6].